Chairman Zhang Shuguang of the board of directors reduced his holdings of Huakang Biomed (08622) by approximately 139 million shares, with an average selling price of around HKD 0.12 per share.

15/01/2025

GMT Eight

According to the latest information from the Hong Kong Stock Exchange, on January 10th, Chairman Zhang Shuguang of the board of directors reduced his holdings of HUAKANG BIOMED (08622) by 138.672 million shares, with a price of HKD 0.1175 per share, totaling 16.29396 million Hong Kong dollars. After the reduction, the latest number of shares held is 4 million shares, and the latest shareholding ratio is 0.8%.

Gdh Supertime Group (001338.SZ) announced that its net profit for the year 2024 is expected to increase by 49.80% to 94.74% to reach between 2.6 billion yuan and 3.38 billion yuan.

Macau: Preliminary statistics show that the foreign exchange reserves as of the end of December 2024 were $29.39 billion.

Contact: contact@gmteight.com

Chairman Zhang Shuguang of the board of directors reduced his holdings of Huakang Biomed (08622) by approximately 139 million shares, with an average selling price of around HKD 0.12 per share.

RECOMMEND

US Stock Market Move | Intuitive Surgical, Inc. (ISRG.US) rose more than 6.4%, with its stock price briefly reaching a new all-time high.

US Stock Market Move | NVIDIA Corporation holds the concept of strong offensive inventory, and Nano X Imaging (NNOX.US) surged by more than 21%.

US Stock Market Move | Goldman Sachs Group, Inc. has rated the company as a "buy" with Micron Technology, Inc. (MU.US) rising over 6%.